Intracellular PD Modelling (PDi) for the Prediction of Clinical Activity of Increased Rifampicin Dosing. (2019)
Attributed to:
Tropical Infectious Disease Consortium: Sustaining, Expanding and Accelerating Product Development
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.3390/pharmaceutics11060278
PubMed Identifier: 31200534
Publication URI: http://europepmc.org/abstract/MED/31200534
Type: Journal Article/Review
Volume: 11
Parent Publication: Pharmaceutics
Issue: 6
ISSN: 1999-4923